DE69105212D1 - Aerosolzubereitung, die beclometason 17,21-dipropionat enthält. - Google Patents

Aerosolzubereitung, die beclometason 17,21-dipropionat enthält.

Info

Publication number
DE69105212D1
DE69105212D1 DE69105212T DE69105212T DE69105212D1 DE 69105212 D1 DE69105212 D1 DE 69105212D1 DE 69105212 T DE69105212 T DE 69105212T DE 69105212 T DE69105212 T DE 69105212T DE 69105212 D1 DE69105212 D1 DE 69105212D1
Authority
DE
Germany
Prior art keywords
dipropionate
beclometason
preparation containing
aerosol preparation
aerosol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Revoked
Application number
DE69105212T
Other languages
English (en)
Other versions
DE69105212T2 (de
Inventor
Robert Schultz
David Schultz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
3M Co
Original Assignee
Minnesota Mining and Manufacturing Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24400688&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69105212(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Minnesota Mining and Manufacturing Co filed Critical Minnesota Mining and Manufacturing Co
Application granted granted Critical
Publication of DE69105212D1 publication Critical patent/DE69105212D1/de
Publication of DE69105212T2 publication Critical patent/DE69105212T2/de
Anticipated expiration legal-status Critical
Revoked legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69105212T 1990-10-18 1991-10-09 Aerosolzubereitung, die beclometason 17,21-dipropionat enthält. Revoked DE69105212T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59969490A 1990-10-18 1990-10-18
PCT/US1991/007574 WO1992006675A1 (en) 1990-10-18 1991-10-09 Aerosol formulation comprising beclomethasone 17,21 dipropionate

Publications (2)

Publication Number Publication Date
DE69105212D1 true DE69105212D1 (de) 1994-12-22
DE69105212T2 DE69105212T2 (de) 1995-03-23

Family

ID=24400688

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69105212T Revoked DE69105212T2 (de) 1990-10-18 1991-10-09 Aerosolzubereitung, die beclometason 17,21-dipropionat enthält.

Country Status (12)

Country Link
EP (1) EP0553298B1 (de)
JP (2) JP2769925B2 (de)
AT (1) ATE114112T1 (de)
AU (1) AU658854B2 (de)
BR (1) BR1100339A (de)
CA (1) CA2094266C (de)
DE (1) DE69105212T2 (de)
DK (1) DK0553298T3 (de)
ES (1) ES2064160T3 (de)
HK (1) HK130397A (de)
NZ (1) NZ240237A (de)
WO (1) WO1992006675A1 (de)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8828477D0 (en) 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
DE4123663A1 (de) * 1991-07-17 1993-01-21 Schwabe Willmar Gmbh & Co Aerosol-zubereitung und verwendung eines treibmittels dafuer
US5736124A (en) * 1991-12-12 1998-04-07 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicament
NZ246046A (en) * 1991-12-12 1995-12-21 Glaxo Group Ltd Aerosol comprising a particulate medicament in a fluorocarbon or chlorofluorohydrocarbon and a polar cosolvent
US5674471A (en) * 1991-12-12 1997-10-07 Glaxo Group Limited Aerosol formulations containing P134a and salbutamol
US5658549A (en) * 1991-12-12 1997-08-19 Glaxo Group Limited Aerosol formulations containing propellant 134a and fluticasone propionate
US5744123A (en) * 1991-12-12 1998-04-28 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
IL104068A (en) 1991-12-12 1998-10-30 Glaxo Group Ltd Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
US5683676A (en) * 1991-12-12 1997-11-04 Glaxo Group Limited Canister containing aerosol formulations containing P134a and particulate medicaments
ATE171865T1 (de) 1991-12-12 1998-10-15 Glaxo Group Ltd Arzneimittel
US5916540A (en) 1994-10-24 1999-06-29 Glaxo Group Limited Aerosol formulations containing P134A and/or P227 and particulate medicament
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
GB9202519D0 (en) * 1992-02-06 1992-03-25 Glaxo Group Ltd Medicaments
MX9304585A (es) * 1992-07-31 1994-03-31 Glaxo Group Ltd Formulacion farmaceutica en aerosol, lata adecuada para liberar la formulacion e inhalador de dosis dosificada que comprende la lata.
US5833950A (en) * 1992-07-31 1998-11-10 Glaxo Group Limited Aerosol formulations containing beclomethasone dipropionate-1, 1, 1, 2-tetrafluoroethane solvate
US5593661A (en) * 1993-03-29 1997-01-14 Henry; Richard A. Lidocaine aerosol anaesthetic
DK0735884T3 (da) * 1993-12-20 2000-10-09 Minnesota Mining & Mfg Flunisolid-aerosolformuleringer
PE44995A1 (es) * 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
US5653961A (en) * 1995-03-31 1997-08-05 Minnesota Mining And Manufacturing Company Butixocort aerosol formulations in hydrofluorocarbon propellant
US5874481A (en) * 1995-06-07 1999-02-23 Alliance Pharmaceutical Corp. Fluorochemical solutions for the delivery of lipophilic pharmaceutical agents
KR100392280B1 (ko) * 1995-06-27 2003-11-19 베링거 인겔하임 카게 추진제비함유흡입성에어로졸을제조하기위한안정한추진제비함유약제학적용액
DE19616573C2 (de) 1996-04-25 1999-03-04 Pari Gmbh Verwendung unterkritischer Treibmittelmischungen und Aerosole für die Mikronisierung von Arzneimitteln mit Hilfe dichter Gase
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
JPH1067655A (ja) * 1996-08-23 1998-03-10 Nippon Hoechst Marion Roussel Kk 喘息治療用エアゾール剤
US6068832A (en) * 1996-08-29 2000-05-30 Schering Corporation Chlorofluorocarbon-free mometasone furoate aerosol formulations
ATE301991T1 (de) * 1996-12-04 2005-09-15 Link Products Ltd Arzneimittel zusammensetzungen und vorrichtungen zu deren verabreichung
US6120752A (en) * 1997-05-21 2000-09-19 3M Innovative Properties Company Medicinal aerosol products containing formulations of ciclesonide and related steroids
GB2326334A (en) † 1997-06-13 1998-12-23 Chiesi Farma Spa Pharmaceutical aerosol compositions
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6433040B1 (en) 1997-09-29 2002-08-13 Inhale Therapeutic Systems, Inc. Stabilized bioactive preparations and methods of use
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
GB2332372B (en) * 1997-12-08 2002-08-14 Minnesota Mining & Mfg Pharmaceutical aerosol compositions
US6086376A (en) * 1998-01-30 2000-07-11 Rtp Pharma Inc. Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant
GB9807232D0 (en) 1998-04-03 1998-06-03 Univ Cardiff Aerosol composition
US6264923B1 (en) 1998-05-13 2001-07-24 3M Innovative Properties Company Medicinal aerosol formulation of ciclesonide and related compounds
US6451285B2 (en) 1998-06-19 2002-09-17 Baker Norton Pharmaceuticals, Inc. Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
IT1303788B1 (it) 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
US6004537A (en) * 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
US6290930B1 (en) 1998-12-18 2001-09-18 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes and budesonide
DE60031504T2 (de) 1999-09-11 2007-04-05 Glaxo Group Ltd., Greenford Fluticasonpropionat arzneizubereitung
ES2238334T3 (es) * 1999-12-24 2005-09-01 Glaxo Group Limited Formulacion farmaceutica en aerosol de salmeterol y propionato de fluticasona.
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
TWI290473B (en) 2000-05-10 2007-12-01 Alliance Pharma Phospholipid-based powders for drug delivery
FR2813877B1 (fr) 2000-09-11 2002-12-06 Cezus Cie Europ Du Zirconium Procede de separation de metaux tels que le zirconium et l'hafnium
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
PT1458360E (pt) 2001-12-19 2011-07-13 Novartis Ag Derivados de indole como agonistas do recetor s1p1
EP1340503A1 (de) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Lösung Aerosol Formulierung von Estern von 3,17-dihydroxy Oestratrien-Derivaten zur Lungenverabreichung
BRPI0312007B1 (pt) 2002-06-25 2015-04-14 Acrux Dds Pty Ltd Composição farmacêutica para administração transcutânea de testosterona ou fentanil e uso da dita composição
AUPS317302A0 (en) * 2002-06-25 2002-07-18 Drug Delivery Solutions Pty Ltd Metastable pharmaceutical compositions
CA2528479A1 (en) 2003-06-13 2004-12-23 Altana Pharma Ag Formoterol and ciclesonide combination
CA2538419C (en) 2003-09-16 2012-07-03 Altana Pharma Ag Use of ciclesonide for the treatment of respiratory diseases
US8148377B2 (en) 2007-02-11 2012-04-03 Map Pharmaceuticals, Inc. Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile
US8652443B2 (en) 2008-02-14 2014-02-18 Precision Dermatology, Inc. Foamable microemulsion compositions for topical administration
AR079451A1 (es) 2009-12-18 2012-01-25 Nycomed Gmbh Compuestos 3,4,4a,10b-tetrahidro-1h-tiopirano[4,3-c]isoquinolina
PL2926855T3 (pl) 2010-10-12 2019-06-28 Ivax Pharmaceuticals Ireland Urządzenie rozpylające do nosa
WO2012171903A1 (en) 2011-06-15 2012-12-20 Nycomed Gmbh Novel 3,4,4a,10b-tetrahydro-1h-thiopyrano[4,3-c]isoquinoline compounds
AR086915A1 (es) 2011-06-17 2014-01-29 Nycomed Gmbh Derivados de ftalazinona-pirrolopirimidinacarboxamida y composiciones farmaceuticas que los contiene
AU2012296880A1 (en) * 2011-08-18 2014-03-27 Astrazeneca Ab Pharmaceutical aerosol product for administration by oral or nasal inhalation
AU2012312310B2 (en) * 2011-09-20 2016-04-28 Sergeants Pet Care Products, Inc. Interomone compositions and their use to modify behavior in different vertebrate species
US9480688B2 (en) 2011-09-20 2016-11-01 Sergeant's Pet Care Products, Inc. Pheromone compositions and their use to modify behavior in different vertebrate species
WO2018069210A1 (en) 2016-10-10 2018-04-19 Takeda Gmbh Tetrahydrofuro[3,4-c]isoquinolines as inhibitors of pde4
US20200268706A1 (en) * 2017-02-27 2020-08-27 Gregory LEVITIN Combination of furosemide and steroids and application system therefor

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8432063D0 (en) * 1984-12-19 1985-01-30 Riker Laboratories Inc Physically modified steroids
DE4003270A1 (de) * 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgase und ihre verwendung in arzneimittelzubereitungen
IE67185B1 (en) * 1990-02-02 1996-03-06 Fisons Plc Propellant compositions
DE4003272A1 (de) * 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen

Also Published As

Publication number Publication date
JP2769925B2 (ja) 1998-06-25
EP0553298B1 (de) 1994-11-17
DE69105212T2 (de) 1995-03-23
NZ240237A (en) 1994-06-27
WO1992006675A1 (en) 1992-04-30
JPH06501710A (ja) 1994-02-24
CA2094266C (en) 1999-06-01
ATE114112T1 (de) 1994-12-15
BR1100339A (pt) 2000-07-18
ES2064160T3 (es) 1995-01-16
AU658854B2 (en) 1995-05-04
AU9087391A (en) 1992-05-20
HK130397A (en) 1997-09-19
DK0553298T3 (da) 1995-04-18
JPH10182467A (ja) 1998-07-07
CA2094266A1 (fr) 1992-04-19
EP0553298A1 (de) 1993-08-04

Similar Documents

Publication Publication Date Title
DE69105212D1 (de) Aerosolzubereitung, die beclometason 17,21-dipropionat enthält.
DE69231992D1 (de) Fluorchlorkohlenwasserstofffreie Aerosolformulierungen
AU5306486A (en) Drug-containing chlorofluorocarbon aerosol propellent formulations
CA2178473A1 (en) Flunisolide aerosol formulations
DK0625046T3 (da) Farmaceutiske aerosolformuleringer indeholdende beclomethasondipropionat
EP1277467A3 (de) Fluorchlorkohlenwasserstofffreie Aerosolformulierungen
ES2099415T3 (es) Formulaciones de aerosol en suspension.
NO980858D0 (no) Farmasöytiske preparater og anordninger for administrering derav
DE2860796D1 (en) Tantomeric arylaminoimidazoline derivatives, their preparation and pharmaceutical formulations for analgetic application containing them
NO910186L (no) Fremgangsmaate for fremstilling av et oralt inhalerbart, farmasoeytisk atropin-salbutamol-aerosolpreparat.
DK0626173T3 (da) Aerosolpræparat indeholdende fusafungin
NL7901103A (nl) 1,1-digesubstitueerde octahydroindool 2,3-a chinoli- zinen, farmaceutisch aanvaardbare zouten daarvan; werk- wijze voor de bereiding van deze verbindingen, farmaceutische preparaten waarin zich deze verbindingen bevinden, met vaatverwijdende eigenschappen.
MX9707238A (es) Formulaciones en aerosol de butixocort.
CA2141039A1 (en) Surfactant free aerosol formulations containing beclomethasone dipropionate
AU536069B2 (en) An 1,4-dhydropyridine derivative, its preparation and pharmaceutical compositions containing it

Legal Events

Date Code Title Description
8363 Opposition against the patent
8331 Complete revocation